Stock CAPLIPOINT CAPLIN POINT LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:30:46 08/05/2024 pm IST 		5-day change 1st Jan Change
1,296 INR +0.29% Intraday chart for Caplin Point Laboratories Limited -4.43% -4.43%
06/05 Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India MT
16/04 Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution MT

Business Summary

Caplin Point Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing, and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals and sachets (liquids and powders). It also manufactures a range of ointments, creams, gels and lotions. Its principal research and development facilities are in Tamil Nadu, India. Its principal manufacturing facility is in Puducherry, India. It has presence in Latin America (LATAM), Southern Africa and Francophone Africa along with a presence in United States of America and European region. The Company’s subsidiaries include Caplin Point Far East Limited and Caplin Steriles Limited.

Number of employees: 1,642

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
12,694 100.0 % 14,667 100.0 % +15.54%

Sales per region

INR in Million2022Weight2023Weight Delta
Latin America
83.0 %
11,381 87.0 % 12,638 83.0 % +11.05%
United States
14.0 %
1,308 10.0 % 2,132 14.0 % +62.96%
Africa
3.0 %
392 3.0 % 457 3.0 % +16.40%

Managers

Managers TitleAgeSince
Sridhar Ganesan CEO
 Chief Executive Officer 69 28/15/28
D. Muralidharan DFI
 Director of Finance/CFO - 19/16/19
Anto V. ADM
 Chief Administrative Officer - -
Gunasakaran S. CTO
 Chief Tech/Sci/R&D Officer - -
Umesh Setty V. CTO
 Chief Tech/Sci/R&D Officer - -
Venkatram Ganapathy Subramanian CMP
 Compliance Officer - 25/22/25
Partheeban Vivek Siddharth COO
 Chief Operating Officer - 01/10/01
Umapathy V. LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Chellappan C. Paarthipan CHM
 Chairman 71 -
Partheeban Vivek Siddharth COO
 Chief Operating Officer - 01/10/01
Sridhar Ganesan CEO
 Chief Executive Officer 69 28/15/28
Damodaran Sathyanarayanan BRD
 Director/Board Member 64 09/16/09
C. K. Gariyali BRD
 Director/Board Member 75 04/20/04
R. Nagendran BRD
 Director/Board Member - -
S Deenadhayalan BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 75,941,746 19,238,423 ( 25.33 %) 0 25.33 %

Shareholders

NameEquities%Valuation
Paarthipan Vijayalakshmi
24.73 %
18,778,790 24.73 % 297 M ₹
Chellappan C. Paarthipan
18.66 %
14,167,192 18.66 % 224 M ₹
Ashok Gorkey Partheeban
11.92 %
9,050,000 11.92 % 143 M ₹
Partheeban Vivek Siddarth
11.85 %
9,000,000 11.85 % 142 M ₹
May India Property Pvt Ltd.
2.788 %
2,117,000 2.788 % 33 M ₹
Government of India
2.654 %
2,015,336 2.654 % 32 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
1.015 %
770,771 1.015 % 12 M ₹
First Dimension Holdings Pvt Ltd.
0.4872 %
370,000 0.4872 % 6 M ₹
Kiraviz Properties & Consultancy LLP
0.1975 %
150,000 0.1975 % 2 M ₹
Seven Canyons Advisors LLC
0.1796 %
136,400 0.1796 % 2 M ₹

Company contact information

Caplin Point Laboratories Ltd.

Ashvich Tower Developed Plots Industrial Estate

600096, Chennai

+91 44 2496 8000

http://www.caplinpoint.net
address Caplin Point Laboratories Limited(CAPLIPOINT)

Group companies

NameCategory and Sector
Caplin Steriles Ltd.
Logo Caplin Steriles Ltd.

Caplin Steriles Ltd.

Pharmaceuticals: MajorHealth Technology

Caplin Steriles Ltd. manufactures and sells injectable pharmaceutical products. The company was founded on December 12, 2018 and is headquartered in Chennai, India.

Pharmaceuticals: Major
Caplin Onco Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Ratings for Caplin Point Laboratories Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,292 INR
Average target price
1,579 INR
Spread / Average Target
+22.20%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
CAPLIN POINT LABORATORIES LIMITED Stock Caplin Point Laboratories Limited
-4.45% 1.18B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.37% 43.57B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.70% 22.7B
SANDOZ GROUP AG Stock Sandoz Group AG
+16.52% 14.32B
CIPLA LIMITED Stock Cipla Limited
+11.05% 13.42B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+45.10% 11.83B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.84% 6.98B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.33% 5.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CAPLIPOINT Stock
  4. Company Caplin Point Laboratories Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW